RU94046169A - Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения - Google Patents
Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ леченияInfo
- Publication number
- RU94046169A RU94046169A RU94046169/04A RU94046169A RU94046169A RU 94046169 A RU94046169 A RU 94046169A RU 94046169/04 A RU94046169/04 A RU 94046169/04A RU 94046169 A RU94046169 A RU 94046169A RU 94046169 A RU94046169 A RU 94046169A
- Authority
- RU
- Russia
- Prior art keywords
- group
- substituted
- alkyl
- aromatic heterocyclic
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Предлагаются соединения формулы (1): A-X-(CH)-O-A-A-YR, или их таутомерные формы, и/или их фармацевтически приемлемые соли, и/или их фармацевтически приемлемые сольваты, в которых Aпредставляет собой замещенную или незамещенную ароматическую гетероциклическую группу; Aпредставляет собой бензольное кольцо, содержащее три необязательных заместителя; Aпредставляет собой группу формулы - (CH)-CH(OR)-, где Rпредставляет собой замещенный или незамещенный алкил, арил, аралкил или алкилкарбонил, и m является целым числом в интервале от 1 до 5, или Aпредставляет собой группу формулы -(CH)--CH=C(OR)-, где Rи m имеют установленные выше значения; Rпредставляет собой OR, где Rпредставляет собой водород, алкил, арил или аралкил, или Rпредставляет собой ароматическую гетероциклическую группу или -NRR, где Rи R, каждый и независимо, представляет собой водород, алкил или алкилкарбонил, или Rи Rвместе с атомом азота, к которому они присоединены, образуют гетероциклическое кольцо при условии, что Rпредставляет собой ароматическую гетероциклическую группу только тогда, когда Y, определение которому дается ниже, представляет собой связь; X представляет собой NR, где R представляет собой атом водорода, алкильную группу, ацильную группу, аралкильную группу, в которой арильная часть может являться замещенной или незамещенной, или замещенную или незамещенную арильную группу; Y представляет собой СО или CS, или связь, при условии, что Y представляет собой связь только тогда, когда Rпредставляет собой вышеупомянутую ароматическую гетероциклическую группу; и n является целым числом в интервале от 2 до 6; а также способ получения таких соединений, композиции, содержащие таки�
Claims (1)
- Предлагаются соединения формулы (1): A1-X-(CH2)n-O-A2-A3-YR2, или их таутомерные формы, и/или их фармацевтически приемлемые соли, и/или их фармацевтически приемлемые сольваты, в которых A1 представляет собой замещенную или незамещенную ароматическую гетероциклическую группу; A2 представляет собой бензольное кольцо, содержащее три необязательных заместителя; A3 представляет собой группу формулы - (CH2)m-CH(OR1)-, где R1 представляет собой замещенный или незамещенный алкил, арил, аралкил или алкилкарбонил, и m является целым числом в интервале от 1 до 5, или A3 представляет собой группу формулы -(CH2)m-1-CH=C(OR1)-, где R1 и m имеют установленные выше значения; R2 представляет собой OR3, где R3 представляет собой водород, алкил, арил или аралкил, или R2 представляет собой ароматическую гетероциклическую группу или -NR4R5, где R4 и R5, каждый и независимо, представляет собой водород, алкил или алкилкарбонил, или R4 и R5 вместе с атомом азота, к которому они присоединены, образуют гетероциклическое кольцо при условии, что R2 представляет собой ароматическую гетероциклическую группу только тогда, когда Y, определение которому дается ниже, представляет собой связь; X представляет собой NR, где R представляет собой атом водорода, алкильную группу, ацильную группу, аралкильную группу, в которой арильная часть может являться замещенной или незамещенной, или замещенную или незамещенную арильную группу; Y представляет собой СО или CS, или связь, при условии, что Y представляет собой связь только тогда, когда R2 представляет собой вышеупомянутую ароматическую гетероциклическую группу; и n является целым числом в интервале от 2 до 6; а также способ получения таких соединений, композиции, содержащие такие соединения, и применение таких соединений и композиций в медицине.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214185A GB9214185D0 (en) | 1992-07-03 | 1992-07-03 | Novel compounds |
GB9214185.2 | 1992-07-03 | ||
GB929227030A GB9227030D0 (en) | 1992-12-29 | 1992-12-29 | Novel compounds |
GB9227030.5 | 1992-12-29 | ||
GB939311027A GB9311027D0 (en) | 1993-05-28 | 1993-05-28 | Novel compounds |
GB9311027.8 | 1993-05-28 | ||
PCT/GB1993/001363 WO1994001420A1 (en) | 1992-07-03 | 1993-06-29 | Heterocyclic compounds as pharmaceutical |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94046169A true RU94046169A (ru) | 1996-10-27 |
RU2134686C1 RU2134686C1 (ru) | 1999-08-20 |
Family
ID=27266276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94046169A RU2134686C1 (ru) | 1992-07-03 | 1993-06-29 | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
Country Status (19)
Country | Link |
---|---|
US (2) | US6048883A (ru) |
EP (2) | EP0648212B1 (ru) |
JP (1) | JPH07508747A (ru) |
KR (1) | KR950702545A (ru) |
CN (2) | CN1042532C (ru) |
AT (1) | ATE207470T1 (ru) |
AU (1) | AU678974B2 (ru) |
CA (1) | CA2139442A1 (ru) |
CZ (1) | CZ1095A3 (ru) |
DE (1) | DE69331010D1 (ru) |
FI (1) | FI950016A (ru) |
HU (1) | HUT71247A (ru) |
MX (1) | MX9303981A (ru) |
NO (2) | NO305318B1 (ru) |
NZ (1) | NZ253742A (ru) |
PL (2) | PL174610B1 (ru) |
RU (1) | RU2134686C1 (ru) |
SK (1) | SK695A3 (ru) |
WO (1) | WO1994001420A1 (ru) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311661D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9311644D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9315148D0 (en) * | 1993-07-22 | 1993-09-08 | Smithkline Beecham Plc | Novel compounds |
GB9326171D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
AU697545B2 (en) * | 1994-07-29 | 1998-10-08 | Smithkline Beecham Plc | Benzoxazoles and pyridine derivatives useful in the treatment of the ty pe II diabetes |
BR9508468A (pt) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
CA2294385C (en) | 1997-06-18 | 2007-06-05 | Smithkline Beecham P.L.C. | Treatment of diabetes with thiazolidinedione and sulphonylurea |
PL193086B1 (pl) * | 1997-10-27 | 2007-01-31 | Reddys Lab Ltd Dr | Nowe związki tricykliczne i związki pośrednie, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
GB2380997B (en) * | 1997-10-27 | 2003-07-02 | Reddys Lab Ltd Dr | Novel aryl-oxysubstituted alkyl carboxylic acids; process for their preparation and pharmaceutical compositions containing them |
HUP0101110A3 (en) | 1997-10-27 | 2002-06-28 | Reddys Lab Ltd Dr | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6130214A (en) * | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
DE69828445D1 (de) * | 1998-04-23 | 2005-02-03 | Reddys Lab Ltd Dr | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
AR023700A1 (es) | 1998-11-12 | 2002-09-04 | Smithkline Beecham Plc | Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina |
DE69939485D1 (de) | 1998-11-12 | 2008-10-16 | Smithkline Beecham Plc | Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin |
US7000106B2 (en) * | 1999-03-26 | 2006-02-14 | Siemens Communications, Inc. | Methods and apparatus for kernel mode encryption of computer telephony |
US6972294B1 (en) | 1999-04-20 | 2005-12-06 | Novo Nordisk, A/S | Compounds, their preparation and use |
DE60005973T2 (de) | 1999-08-27 | 2004-05-13 | Eli Lilly And Co., Indianapolis | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren |
SE9904415D0 (sv) * | 1999-12-03 | 1999-12-03 | Astra Ab | New process |
EE05082B1 (et) * | 2000-01-19 | 2008-10-15 | Cadila Healthcare Ltd. | Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon |
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
AU2831801A (en) * | 2000-01-28 | 2001-08-07 | Novo Nordisk A/S | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
US6569901B2 (en) | 2000-01-28 | 2003-05-27 | Novo Nordisk A/S | Alkynyl-substituted propionic acid derivatives, their preparation and use |
US6509374B2 (en) | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
US6559335B2 (en) | 2000-09-22 | 2003-05-06 | Dr. Reddy's Laboratories Limited | Process for the preparation of 3-aryl-2-hydroxy propanoic acid |
TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
AU2002342244B2 (en) | 2001-05-15 | 2005-06-16 | F. Hoffmann-La Roche Ag | Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes |
US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
US7371777B2 (en) | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
AU2002351752A1 (en) | 2001-12-29 | 2003-07-30 | Novo Nordisk A/S | Combined use of a glp-1 compound and another drug for treating dyslipidemia |
US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
PT1537091E (pt) * | 2002-08-30 | 2010-11-11 | Hoffmann La Roche | Novos compostos de 2-ariltiazole como agonistas de ppar-alfa e de ppar-gama |
BR0314261A (pt) | 2002-09-12 | 2005-07-26 | Hoffmann La Roche | Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento |
RU2315767C2 (ru) | 2002-11-25 | 2008-01-27 | Ф.Хоффманн-Ля Рош Аг | Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
US6653334B1 (en) | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
JP2007500219A (ja) * | 2003-05-16 | 2007-01-11 | アンビット バイオサイエンシス コーポレーション | 複素環化合物およびその使用法 |
US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
US20050182125A1 (en) * | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
BRPI0607433A2 (pt) * | 2005-02-25 | 2009-09-08 | Takeda Pharmaceutical | composto ou um sal do mesmo, pró-droga, agente farmacêutico, inibidor de peptidase, uso de um composto ou de uma pró-droga do mesmo, e, métodos de prevenção ou tratamento de doenças, de inibição de peptidase em um mamìfero, e de produção de um composto |
WO2008117982A1 (en) * | 2007-03-28 | 2008-10-02 | Crystal Genomics, Inc. | Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same |
EP2154131A4 (en) * | 2007-04-26 | 2011-09-21 | Pharmafrontier Co Ltd | INHIBITOR OF THE G-PROTEIN-COUPLED RECEPTOR AND PHARMACEUTICAL PRODUCT |
CN107056671A (zh) | 2011-01-31 | 2017-08-18 | 卡迪拉保健有限公司 | 脂肪代谢障碍的治疗 |
EA201592020A1 (ru) | 2013-04-22 | 2016-05-31 | Кадила Хелзкэр Лимитед | Новая композиция для неалкогольной жировой болезни печени (нажбп) |
ES2889916T3 (es) | 2013-05-30 | 2022-01-14 | Cadila Healthcare Ltd | Un procedimiento para la preparación de pirroles con actividades hipolipidémicas e hipocolesterémicas |
TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
IN2013MU02470A (ru) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
CN103467409B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 取代的四氮唑羧酸类化合物及其用途 |
CN103467407B (zh) * | 2013-09-03 | 2015-04-22 | 浙江医药高等专科学校 | 四氮唑羧酸类化合物及其用途 |
CN103467405B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物、其制备方法和用途 |
CN103467406B (zh) * | 2013-09-03 | 2014-12-17 | 浙江医药高等专科学校 | 卤素取代的四氮唑羧酸类化合物、其制备方法和用途 |
CN103467408B (zh) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物及其用途 |
WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
WO2018104916A1 (en) | 2016-12-09 | 2018-06-14 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232925A (en) * | 1987-09-04 | 1993-08-03 | Beecham Group P.L.C. | Compounds |
US5194443A (en) * | 1987-09-04 | 1993-03-16 | Beecham Group P.L.C. | Compounds |
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
-
1993
- 1993-06-29 EP EP93914841A patent/EP0648212B1/en not_active Expired - Lifetime
- 1993-06-29 HU HU9500006A patent/HUT71247A/hu unknown
- 1993-06-29 PL PL93307087A patent/PL174610B1/pl unknown
- 1993-06-29 PL PL93316129A patent/PL176885B1/pl unknown
- 1993-06-29 RU RU94046169A patent/RU2134686C1/ru active
- 1993-06-29 EP EP99204395A patent/EP1000938A1/en not_active Withdrawn
- 1993-06-29 AT AT93914841T patent/ATE207470T1/de not_active IP Right Cessation
- 1993-06-29 CZ CZ9510A patent/CZ1095A3/cs unknown
- 1993-06-29 US US08/360,755 patent/US6048883A/en not_active Expired - Fee Related
- 1993-06-29 CA CA002139442A patent/CA2139442A1/en not_active Abandoned
- 1993-06-29 JP JP6503071A patent/JPH07508747A/ja active Pending
- 1993-06-29 AU AU45068/93A patent/AU678974B2/en not_active Ceased
- 1993-06-29 WO PCT/GB1993/001363 patent/WO1994001420A1/en not_active Application Discontinuation
- 1993-06-29 DE DE69331010T patent/DE69331010D1/de not_active Expired - Lifetime
- 1993-06-29 NZ NZ253742A patent/NZ253742A/en unknown
- 1993-06-29 SK SK6-95A patent/SK695A3/sk unknown
- 1993-06-29 KR KR1019940704886A patent/KR950702545A/ko not_active Application Discontinuation
- 1993-07-01 MX MX9303981A patent/MX9303981A/es not_active IP Right Cessation
- 1993-07-02 CN CN93109874A patent/CN1042532C/zh not_active Expired - Fee Related
-
1995
- 1995-01-02 NO NO950009A patent/NO305318B1/no not_active IP Right Cessation
- 1995-01-02 FI FI950016A patent/FI950016A/fi unknown
- 1995-06-02 US US08/458,335 patent/US5869495A/en not_active Expired - Fee Related
-
1998
- 1998-05-14 CN CN98108909A patent/CN1215724A/zh active Pending
-
1999
- 1999-01-19 NO NO990227A patent/NO990227D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO990227L (no) | 1995-03-02 |
SK695A3 (en) | 1995-07-11 |
FI950016A (fi) | 1995-03-02 |
EP1000938A1 (en) | 2000-05-17 |
MX9303981A (es) | 1994-04-29 |
CN1095716A (zh) | 1994-11-30 |
EP0648212A1 (en) | 1995-04-19 |
ATE207470T1 (de) | 2001-11-15 |
AU678974B2 (en) | 1997-06-19 |
NO950009L (no) | 1995-03-02 |
AU4506893A (en) | 1994-01-31 |
WO1994001420A1 (en) | 1994-01-20 |
PL307087A1 (en) | 1995-05-02 |
RU2134686C1 (ru) | 1999-08-20 |
NO990227D0 (no) | 1999-01-19 |
US5869495A (en) | 1999-02-09 |
CA2139442A1 (en) | 1994-01-20 |
NO950009D0 (no) | 1995-01-02 |
NZ253742A (en) | 1997-06-24 |
CN1042532C (zh) | 1999-03-17 |
KR950702545A (ko) | 1995-07-29 |
HUT71247A (en) | 1995-11-28 |
CN1215724A (zh) | 1999-05-05 |
PL176885B1 (pl) | 1999-08-31 |
EP0648212B1 (en) | 2001-10-24 |
DE69331010D1 (de) | 2001-11-29 |
JPH07508747A (ja) | 1995-09-28 |
CZ1095A3 (en) | 1995-10-18 |
NO305318B1 (no) | 1999-05-10 |
US6048883A (en) | 2000-04-11 |
PL174610B1 (pl) | 1998-08-31 |
HU9500006D0 (en) | 1995-03-28 |
FI950016A0 (fi) | 1995-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94046169A (ru) | Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения | |
FI884879A (fi) | Terapeutiskt anvaendbara heterocykliska foereningar. | |
ES2137915T3 (es) | Derivados de tiazolidindiona sustituida. | |
CA2119572A1 (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
AU6129890A (en) | Novel compounds | |
IE811831L (en) | Indoles. | |
ES2150353A1 (es) | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. | |
DE3581566D1 (de) | Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte. | |
PT81855B (pt) | Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem | |
FI956151A (fi) | Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia | |
ATE8389T1 (de) | Amino-alkoxy-pyrazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
DE3887102T2 (de) | Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen. | |
RU94035677A (ru) | Способ получения хлорангидридов кислот |